Should You Buy Sarepta Therapeutics Stock For 50% Gains?

We believe that ​Sarepta Therapeutics stock, a biotech company focused on the discovery and development of RNA-targeted therapeutics and gene therapy for the treatment of rare diseases, is a good buying opportunity at the present time. SRPT stock trades near $83 currently and it is, in fact...